Cancers linked to excess weight make up 40% of all US diagnoses, study finds

CDC researchers said the risk of 13 cancers is increased by being overweight or obese, including cancer of the thyroid, gallbladder, liver, kidney, colon and pancreas. Being overweight also increases the risk of a blood cancer called myeloma, a spinal cancer called meningioma, a type of esophageal cancer, and a type of stomach cancer. The study looked at cancers more likely to occur in people who are overweight or obese. These cancers are linked to being

The Week in Review: April 21, 2017 – April 28, 2017

Friday, April 28, 2017 News Recap Canada New Canadian Testing Guidelines Released: On April 24, 2017, The Canadian Task Force on Preventative Health Care (CTFPHC) published its HCV Screening Guidelines in the CMAJ. The guidelines make the recommendation to continue screening those with known risk factors, but does not include a recommendation to screen the age cohort born between 1945-1975, which has been recommended by many of Canada’s top liver sp...

The Week in Review: April 14, 2017 – April 21, 2017

Friday, April 21, 2017 News Recap Canada Well the last report from the final leg of HepCBC’s Road Trip to BC’s Interior 2017 is in. What a journey!! – and so much work!! This report focusses on events in the Kootenay region of BC, and I’m really impressed at how much Rosemary and Cheryl were able to accomplish!  Amazing. Awareness of hepatitis C in BC’s more remote and small communities is growing and this is due to the hard work of the many advocat...

Hepatitis C Patients at No Elevated Risk of Developing HCC Following DAA Compared to Interferon

Patients were at no elevated risk of developing hepatocellular carcinoma (HCC) after achieving sustained virologic response (SVR) following treatment with direct-acting antiviral therapy (DAA) for hepatitis C compared to interferon therapy, according to results of a meta-analysis reported at the 2017 International Liver Congress (ILC). The data reflected that there was no difference in liver cancer risk following cure with either therapy. However, achievi